Policy

News
Charles Schmidt
Nov. 21, 2021
Gain-of-function research: All in the eye of the beholder
Should work done on coronaviruses in Wuhan, China, be considered “gain-of-function” research? Opinions differ.
Read More

More in Policy

COVID immunity through infection or vaccination: Are they equal?
News

COVID immunity through infection or vaccination: Are they equal?

Oct. 16, 2021

As scientists argue whether a previous bout of covid offers the same amount of protection as vaccinations, people turn to the courts to decide.

Society news briefs: October 2021
Society News

Society news briefs: October 2021

Oct. 14, 2021

Find out everything that’s been going on lately with the American Society for Biochemistry and Molecular Biology.

Collins’ skillful piloting helped NIH steer clear of political minefields
News

Collins’ skillful piloting helped NIH steer clear of political minefields

Oct. 9, 2021

Francis Collins, who is stepping down as chief of the National Institutes of Health, used his communication skills and political insights to help protect the acclaimed federal research institutes through difficult times.

Tackling the growing problem of overmedication
Feature

Tackling the growing problem of overmedication

Sept. 25, 2021

Researchers and pharmacists are seeking solutions to this serious public health problem that disproportionately affects older adults.

Are COVID-19 boosters ethical, with half the world waiting for a first shot?
News

Are COVID-19 boosters ethical, with half the world waiting for a first shot?

Sept. 25, 2021

Scientists debate the medical benefits of booster shots. But there’s another aspect to consider: bioethics.

Scientists must speak out against 'immune-boosting' supplements
Science Communication

Scientists must speak out against 'immune-boosting' supplements

Sept. 18, 2021

Supplements that claim to supercharge your T-cells, make your antibodies hum and otherwise make you invincible are all bunk, and scientists should speak out more about this misinformation.

Society News

Society news briefs: November 2021

Find out everything that’s been going on lately at the American Society for Biochemistry and Molecular Biology.
Society news briefs: November 2021

More in Policy

Personal chemistry: Proteomics tackles privacy concerns
Feature

Personal chemistry: Proteomics tackles privacy concerns

Sept. 9, 2021

Sharing raw data is an important norm for the proteomics community. But as clinical studies become more detailed, researchers may need to clamp down to protect patient privacy.

What does full FDA approval of a vaccine do if it’s already authorized for emergency use?
News

What does full FDA approval of a vaccine do if it’s already authorized for emergency use?

Sept. 4, 2021

While emergency use authorization gets vaccines out to the public more quickly, it doesn’t skip any steps that full approval requires.

Society news briefs
Society News

Society news briefs

Aug. 17, 2021

Find out everything that’s been going on lately with the American Society of Biochemistry and Molecular Biology.

Steps for getting started in science policy
How-to

Steps for getting started in science policy

Aug. 11, 2021

“Science policy is a fast-paced field. You must be able to shift quickly between priorities and projects, sometimes in response to what’s going on that week in federal policy.”

Necessary or not, COVID booster shots are probably on the horizon
News

Necessary or not, COVID booster shots are probably on the horizon

Aug. 7, 2021

In today’s pharmaceutical universe, a simple “safe and effective” determination by the FDA to approve a drug can be manipulated to sell products of questionable value. And drugmakers can profit handsomely

US travel bans: Bizarre and ruthless
Open Letters

US travel bans: Bizarre and ruthless

Aug. 4, 2021

Continuing travel restrictions have prevented the author and thousands of other international scholars from seeing their families for a year and a half.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.